Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study.
Ichikawa M, Suzuki R, Kataoka K, Noda Y, Shindoh J, Matsumoto S, Tanikawa Y, Suzuki K, Baba K, Shindo Y, Kondo M, Imaizumi K, Kume H, Hasegawa Y, Takagi K, Taniguchi H.
Ichikawa M, et al. Among authors: kondo m.
Lung Cancer. 2010 Sep;69(3):319-22. doi: 10.1016/j.lungcan.2009.11.021. Epub 2010 Jan 6.
Lung Cancer. 2010.
PMID: 20053476
Clinical Trial.